menu

Drug Discovery and Development Collaboration

Our novel oligonucleotide drug discovery, development and delivery system provides a range of collaboration opportunities including the creation of new oligonucleotide programs, as well as optimizing programs already underway.

Our proprietary technology offers our collaborators several key benefits and opportunities including:

  1. First-of-its-kind cell-specific, systemic intravenous drug delivery of oligonucleotide drugs to Dectin-1 positive immune cells, offering solution to critical oligonucleotide delivery challenges
  2. Applicability to a broad range of nucleic acids allowing for creation of drug candidates against various diseases/conditions including immune disease, cancer, transplantation, and infectious disease
  3. Framework for rapid creation of novel, patent-protected drug candidates from target gene sequence information to lead optimization within one year
  4. Demonstrated activity promising safety profile

 

Contact NapaJen to Discuss Partnering Opportunities

If you are interested in exploring a collaboration or licensing opportunity with NapaJen, please contact:

Kazuhiro Kawauchi
Business Development Dept.
e-mail: info@napajen.com
e-mail: k.kawauchi@napajen.com
Phone: +81-42-316-6773
cell: +81-70-2493-1146